WINNERS & LOSERS: Time Finance backs buyout; Nostrum sells assets
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More
| Price | 3.50p on 28-08-2026 at 18:05:12 |
|---|---|
| Change | 0.00p 0% |
| Buy | 3.99p |
| Sell | 3.50p |
| Last Trade: | Sell 8.00 at 3.50p |
| Day's Volume: | 2,391,524 |
| Last Close: | 3.50p |
| Open: | 3.475p |
| ISIN: | GB0033711010 |
| Day's Range | 3.475p - 3.75p |
| 52wk Range: | 2.42p - 19.00p |
| Market Capitalisation: | £21.84m |
| VWAP: | 3.59845p |
| Shares in Issue: | 623.91m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Immupharma (IMM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 8 | 3.50p | Uncrossing Trade |
16:40:04 - 28-Aug-26 |
| Sell* | 30,791 | 3.75p | Automatic Execution |
16:29:30 - 28-Aug-26 |
| Sell* | 150,000 | 3.7585p | Ordinary |
16:29:21 - 28-Aug-26 |
| Sell* | 150,000 | 3.7618p | Ordinary |
16:29:20 - 28-Aug-26 |
| Sell* | 150,000 | 3.7952p | Ordinary |
16:29:10 - 28-Aug-26 |
| Sell* | 3,827 | 3.75p | SI Trade |
16:29:09 - 28-Aug-26 |
| Buy* | 5,643 | 3.75p | Automatic Execution |
16:29:09 - 28-Aug-26 |
| Buy* | 82 | 3.75p | Automatic Execution |
16:29:09 - 28-Aug-26 |
| Buy* | 3,484 | 3.75p | Automatic Execution |
16:29:09 - 28-Aug-26 |
| Buy* | 40,000 | 3.725p | Ordinary |
16:29:05 - 28-Aug-26 |
Immupharma (IMM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 10th Aug 2026 7:00 am | RNS | Bioanalytical CRO partner for Kapiglucagon |
| 22nd Jul 2026 7:00 am | RNS | Thermo Fisher CDMO selected for Kapiglucagon pro |
| 25th Jun 2026 1:20 pm | RNS | 2026 RESULT OF ANNUAL GENERAL MEETING |
| 25th Jun 2026 7:00 am | RNS | ImmuPharma appoints Bachem for Kapiglucagon API |
| 24th Jun 2026 7:00 am | RNS-R | University of Murcia research relating to P140 |
| 4th Jun 2026 7:10 am | RNS-R | Incanthera plc – Corporate Update & Board Changes |
| 2nd Jun 2026 7:00 am | RNS | Notice of AGM & Annual Report & Accounts |
| 27th May 2026 7:00 am | RNS | Final Results |
| 5th May 2026 7:00 am | RNS | IMM initiatesIND-Enabling Program for Kapiglucagon |
| 10th Apr 2026 7:00 am | RNS | Holding(s) in Company |